314 related articles for article (PubMed ID: 25542083)
1. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.
Zanotto-Filho A; Braganhol E; Klafke K; Figueiró F; Terra SR; Paludo FJ; Morrone M; Bristot IJ; Battastini AM; Forcelini CM; Bishop AJR; Gelain DP; Moreira JCF
Cancer Lett; 2015 Mar; 358(2):220-231. PubMed ID: 25542083
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
[TBL] [Abstract][Full Text] [Related]
3. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
Wu H; Liu Q; Cai T; Chen YD; Wang ZF
Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619
[TBL] [Abstract][Full Text] [Related]
4. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
5. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
Bagherian A; Mardani R; Roudi B; Taghizadeh M; Banfshe HR; Ghaderi A; Davoodvandi A; Shamollaghamsari S; Hamblin MR; Mirzaei H
J Mol Neurosci; 2020 Oct; 70(10):1471-1483. PubMed ID: 32666415
[TBL] [Abstract][Full Text] [Related]
6. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition.
Zhang P; Sun S; Li N; Ho ASW; Kiang KMY; Zhang X; Cheng YS; Poon MW; Lee D; Pu JKS; Leung GKK
J Neurooncol; 2017 May; 132(3):393-400. PubMed ID: 28293765
[TBL] [Abstract][Full Text] [Related]
7. Targeting autophagy to sensitive glioma to temozolomide treatment.
Yan Y; Xu Z; Dai S; Qian L; Sun L; Gong Z
J Exp Clin Cancer Res; 2016 Feb; 35():23. PubMed ID: 26830677
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
Li H; Liu Y; Jiao Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y
Oncol Rep; 2016 Jan; 35(1):343-51. PubMed ID: 26498391
[TBL] [Abstract][Full Text] [Related]
10. Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria.
Lohitesh K; Saini H; Srivastava A; Mukherjee S; Roy A; Chowdhury R
Oncol Rep; 2018 Jun; 39(6):2787-2796. PubMed ID: 29658588
[TBL] [Abstract][Full Text] [Related]
11. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
13. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas.
Gonçalves RM; Agnes JP; Delgobo M; de Souza PO; Thomé MP; Heimfarth L; Lenz G; Moreira JCF; Zanotto-Filho A
Biochem Pharmacol; 2019 May; 163():440-450. PubMed ID: 30878553
[TBL] [Abstract][Full Text] [Related]
14. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells.
Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA
Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide.
Quann K; Gonzales DM; Mercier I; Wang C; Sotgia F; Pestell RG; Lisanti MP; Jasmin JF
Cell Cycle; 2013 May; 12(10):1510-20. PubMed ID: 23598719
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response.
Sesen J; Dahan P; Scotland SJ; Saland E; Dang VT; Lemarié A; Tyler BM; Brem H; Toulas C; Cohen-Jonathan Moyal E; Sarry JE; Skuli N
PLoS One; 2015; 10(4):e0123721. PubMed ID: 25867026
[TBL] [Abstract][Full Text] [Related]
17. BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide.
Chen CM; Syu JP; Way TD; Huang LJ; Kuo SC; Lin CT; Lin CL
Int J Mol Med; 2015 Nov; 36(5):1244-52. PubMed ID: 26329365
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
[TBL] [Abstract][Full Text] [Related]
19. Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.
Banelli B; Daga A; Forlani A; Allemanni G; Marubbi D; Pistillo MP; Profumo A; Romani M
Oncotarget; 2017 May; 8(21):34896-34910. PubMed ID: 28432280
[TBL] [Abstract][Full Text] [Related]
20. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma.
Zanotto-Filho A; Braganhol E; Edelweiss MI; Behr GA; Zanin R; Schröder R; Simões-Pires A; Battastini AM; Moreira JC
J Nutr Biochem; 2012 Jun; 23(6):591-601. PubMed ID: 21775121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
